Anti-psychotics are drugs used in the treatment of psychosis which are a
group of disorders characterized by serious distortion of thought, behavior,
recognition of reality and perception, delusions and hallucinations.
Antipsychotic
Drugs Market is expected to register a CAGR of
5.7% to reach USD 33.59 Billion by 2030
The market for psychotics represents a huge potential as can be seen
from the following estimates by World Health Organization (WHO)
Depression affects an estimated 300 million people in the world.
Bipolar affective disorder takes a toll on about 60 million people
worldwide.
Schizophrenia, a severe mental disorder, affects about 21 million people
worldwide.
Dementia has a prevalence in about 47.5 million people worldwide
One fourth of people are affected by mental or neurological disorders at
some point in their lives.
Thus the current number of untapped patients are of an order of around
450 million. Other market drivers are growing awareness and focus on mental
illness, inclusion of more conditions such as learning disability in the mental
disorders segment, rise of geriatrics population and mental hospitals etc.
The market constraints are social stigma and discrimination, poor
efficacy and efficiency of anti-psychotic drugs, serious side effects such as
habit forming potential etc. Patent expiry is also constraining the market as a
number of established brands such as, Zyprexa, Seroquel, Risperdal lost
patents. The drug development pipeline represents another miserable situation.
The development pipeline is poor with a few if any novel acting drugs. The
market represents numerous drugs with same mechanism of action and similar
therapeutic profile which has hampered the market. Strict regulatory framework
is another barrier along with the technical difficulties with performing
clinical trials for these class of drugs as it is difficult to separate cause
and effect in case of anti-psychotic drugs.
Major Key
Players:
The major Antipsychotic Drugs Market Players are: Eli Lilly & Co.,
Bristol-Myers Squibb, AstraZeneca, Pfizer Inc., GlaxoSmithKline Plc., Johnson
& Johnson and others.
Segment Analysis
Market Research
Future report offers an all-inclusive segmental analysis of the antipsychotic
drugs market on the basis of application and generation.
Based on
therapeutic application, it is segmented into injectable antipsychotics dementia,
depression, bipolar disorder, schizophrenia and others. Of these, psychotic
depression and schizophrenia will have the largest share in the antipsychotic
drugs market over the predicted years.
Based on
generation, the antipsychotic drugs market is segmented into first, second,
third. The first generation is also called neuroleptics or typical
antipsychotics and the second generation is also called atypical
antipsychotics.
Regional Analysis
Based on the region, the global market is segmented into North America, Europe,
Asia-Pacific, and the Rest of the World (RoW).
As per the analysis, the global market is projected to be dominated by
North America owing to the rising population being affected by psychosis. The
US and Canada are expected to make significant participation due to the
increasing cases of schizophrenia and insomnia. Further, the presence of
established key players in the region is predicted to augment the market in the
coming period. The developing healthcare infrastructure is anticipated to
strengthen the market during the review period.
Europe is expected to acquire significant market value during the
forecast period, thriving at a notable CAGR. The region is anticipated to grow
due to the expanding patient pool. The on-going development in the concerned
field is likely to bolster the market during the assessment period. Further,
the development of healthcare infrastructure can augment the market during the
evaluation period.
The APAC region is expected to garner substantial market value during
the review period. The expanding patient pool with the growing innovation in
medical devices is likely to grow the market in the forecast period. Developing
countries like India, China, and Japan are projected to play a crucial role in
strengthening the regional market due to the on-going development of the
healthcare sector. Furthermore, the on-going R&D in the field is expected
to drive the regional market at a fast pace in the coming period.
The MEA region is anticipated to witness steady growth during the forecast
period due to the developing healthcare infrastructure. The presence of Middle
East countries like Qatar and Saudi Arabia are expected to make more
significant participation than the African countries due to economic stability.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
